Influenza Hemagglutinin Stem Nanoparticle Vaccine Induces Cross-Group 1 Neutralizing Antibodies in Healthy Adults, Impact of SARS-CoV-2 Variants on Inpatient Clinical Outcome, and Gut Microbiota Derived Symbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19

5 views
August 3, 2023
0 Comments
Login to view comments. Click here to Login